KB
Kharabela Behera
About Kharabela Behera
Data last updated:
Kharabela Behera has 6 years in corporate governance. Holds Director role. Currently with 2 companies, including Oncogene Pharmaceuticals Private Limited and Utkal Cancer Care Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Utkal Cancer Care Private Limited at ₹17.5 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 06 Jun 2020 | 2020 | ₹17.5 Lakh (FY 2025) | Active | |
| Director | 15 Jun 2021 | 2021 | – | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Kharabela Behera
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kharabela Behera
Kharabela Behera has 6 years in corporate governance. Holds Director role. Currently with 2 companies, including Oncogene Pharmaceuticals Private Limited and Utkal Cancer Care Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Utkal Cancer Care Private Limited at ₹17.5 Lakh (FY 2025).
Kharabela Behera is associated with 2 companies as Director, including Utkal Cancer Care Private Limited (₹17.5 Lakh), Oncogene Pharmaceuticals Private Limited.
Kharabela Behera has expertise in General Business.
Kharabela Behera has 6 years in corporate governance.
By reported revenue, the largest current company of Kharabela Behera is Utkal Cancer Care Private Limited, with revenue of ₹17.5 Lakh (FY 2025).
Kharabela Behera currently holds positions at 2 companies: Utkal Cancer Care Private Limited (₹17.5 Lakh), Oncogene Pharmaceuticals Private Limited.